Karyopharm Therapeutics
KPTI
KPTI
87 hedge funds and large institutions have $41.2M invested in Karyopharm Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
-4
Holders Change %
-4.4%
% of All Funds
1.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
21
Reduced
23
Closed
18
Calls
$196K
Puts
$47K
Net Calls
+$149K
Net Calls Change
-$712K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$2.38M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
$4.27M |
| 3 |
Jane Street
New York
|
$506K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$449K |
| 5 |
Marshall Wace
London,
United Kingdom
|
$1.63M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FCMT
101
Founders Capital Management (Texas)
Houston,
Texas
| – | -$1.66K | -133 | Closed |
|
|
GSEP
102
Golden State Equity Partners
South Coast Metro,
California
| – | -$1.49K | -120 | Closed |
|
103
Lazard Asset Management
New York
| – | -$1K | -105 | Closed |
|
|
AAP
104
Arax Advisory Partners
Denver,
Colorado
| – | -$447 | -36 | Closed |
|
|
AF
105
Advisornet Financial
Minnetonka,
Minnesota
| – | -$166 | -13 | Closed |
|